1822 related articles for article (PubMed ID: 33709980)
1. Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers.
Qiang Z; Wang B; Garrett BC; Rainey RP; Superko HR
Curr Opin Cardiol; 2021 May; 36(3):367-373. PubMed ID: 33709980
[TBL] [Abstract][Full Text] [Related]
2. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Zhu Z; Wang M; Lin W; Cai Q; Zhang L; Chen D; Liu F; Xiong X; Chu J; Peng J; Chen K
Immun Inflamm Dis; 2021 Dec; 9(4):1071-1100. PubMed ID: 34405950
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
[TBL] [Abstract][Full Text] [Related]
4. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Feldman A; D'Andréa Saba Arruda G; de Souza AS; de Albuquerque DC; Mazza L; Santos MF; Salvador NZ; Gibson CM; Granger CB; Alexander JH; de Souza OF;
Am Heart J; 2020 Aug; 226():49-59. PubMed ID: 32502882
[TBL] [Abstract][Full Text] [Related]
5. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis.
Dalia T; Lahan S; Ranka S; Acharya P; Gautam A; Goyal A; Mastoris I; Sauer A; Shah Z
Indian Heart J; 2021; 73(1):91-98. PubMed ID: 33714416
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis.
Walker C; Deb S; Ling H; Wang Z
J Pharm Pharm Sci; 2020; 23():396-405. PubMed ID: 33086028
[TBL] [Abstract][Full Text] [Related]
7. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
Cappuccio FP; Siani A
Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1227-1235. PubMed ID: 32595085
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Guo J; Huang Z; Lin L; Lv J
J Am Heart Assoc; 2020 Apr; 9(7):e016219. PubMed ID: 32233755
[No Abstract] [Full Text] [Related]
9. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.
Li X; Pan X; Li Y; An N; Xing Y; Yang F; Tian L; Sun J; Gao Y; Shang H; Xing Y
Crit Care; 2020 Jul; 24(1):468. PubMed ID: 32723362
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
Guo T; Fan Y; Chen M; Wu X; Zhang L; He T; Wang H; Wan J; Wang X; Lu Z
JAMA Cardiol; 2020 Jul; 5(7):811-818. PubMed ID: 32219356
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease 2019 and cardiovascular system: A narrative review.
Kwenandar F; Japar KV; Damay V; Hariyanto TI; Tanaka M; Lugito NPH; Kurniawan A
Int J Cardiol Heart Vasc; 2020 Aug; 29():100557. PubMed ID: 32550259
[TBL] [Abstract][Full Text] [Related]
12. Myocardial injury in severe and critical coronavirus disease 2019 patients.
Guo H; Shen Y; Wu N; Sun X
J Card Surg; 2021 Jan; 36(1):82-88. PubMed ID: 33135188
[TBL] [Abstract][Full Text] [Related]
13. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Pranata R; Permana H; Huang I; Lim MA; Soetedjo NNM; Supriyadi R; Soeroto AY; Alkatiri AA; Firman D; Lukito AA
Diabetes Metab Syndr; 2020; 14(5):983-990. PubMed ID: 32615377
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19.
Wungu CDK; Khaerunnisa S; Putri EAC; Hidayati HB; Qurnianingsih E; Lukitasari L; Humairah I; Soetjipto
Int J Infect Dis; 2021 Apr; 105():551-559. PubMed ID: 33711519
[TBL] [Abstract][Full Text] [Related]
15. Cardiac manifestations in COVID-19 patients-A systematic review.
Shafi AMA; Shaikh SA; Shirke MM; Iddawela S; Harky A
J Card Surg; 2020 Aug; 35(8):1988-2008. PubMed ID: 32652713
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
Wallentin L; Lindbäck J; Eriksson N; Hijazi Z; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Oldgren J; Siegbahn A
Eur Heart J; 2020 Nov; 41(41):4037-4046. PubMed ID: 32984892
[TBL] [Abstract][Full Text] [Related]
17. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
19. Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France.
Oussalah A; Gleye S; Clerc Urmes I; Laugel E; Callet J; Barbé F; Orlowski S; Malaplate C; Aimone-Gastin I; Caillierez BM; Merten M; Jeannesson E; Kormann R; Olivier JL; Rodriguez-Guéant RM; Namour F; Bevilacqua S; Losser MR; Levy B; Kimmoun A; Gibot S; Thilly N; Frimat L; Schvoerer E; Guéant JL
Clin Infect Dis; 2020 Dec; 71(9):2447-2456. PubMed ID: 32623470
[TBL] [Abstract][Full Text] [Related]
20. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.
Parohan M; Yaghoubi S; Seraji A
Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):665-677. PubMed ID: 32567326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
